Brian Culley

Brian Culley

Chief Executive Officer at LINEAGE CELL THERAPEUTICS, INC.

Net worth: 339 836 $ as of 31/05/2026

54 year
Health Technology
Consumer Services
Distribution Services

Profile

Brian M.
Culley
is currently President, Chief Executive Officer, CAO & Director at Lineage Cell Therapeutics, Inc. since 2022.
Mr. Culley is also Chief Executive Officer at Asterias Biotherapeutics, Inc. since 2019.
Formerly, Mr. Culley was Chief Executive Officer & Director at Mast Therapeutics, Inc. from 2011 to 2017.
Mr. Culley was Chief Executive Officer at Manuka, Inc. from 2017 to 2018.
Mr. Culley was Chief Executive Officer & Director at Savara, Inc. Mr. Culley was Director at Orphagen Pharmaceuticals from 2017 to 2022.
Mr. Culley was Director-Business Development & Marketing at iTherX Pharmaceuticals, Inc. from 2002 to 2004.
Mr. Culley was Licensing & Marketing Associate at the University of California, Berkeley from 1999 to 2000.
Mr. Culley completed undergraduate studies at Boston College, graduate studies at the University of California, Santa Barbara, and earned an MBA from Johnson Graduate School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/04/2026 255,516 ( 0.1% ) 339 836 $ 31/05/2026

Brian Culley active positions

CompaniesPositionStart
LINEAGE CELL THERAPEUTICS, INC. Chief Executive Officer 17/09/2018
ASTERIAS BIOTHERAPEUTICS INC Chief Executive Officer 08/03/2019

Former positions of Brian Culley

CompaniesPositionEnd
Director/Board Member 01/12/2022
MANUKA, INC. Chief Executive Officer 17/09/2018
Chief Executive Officer 28/04/2017
SAVARA INC. Chief Executive Officer 27/04/2017
Sales & Marketing 01/01/2004
See the detail of Brian Culley's experience

Training of Brian Culley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Distribution Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology